Reversibility of cortical hyperostosis following long-term prostaglandin E1 therapy in infants with ductus-dependent congenital heart disease

1988 ◽  
Vol 18 (2) ◽  
pp. 149-153 ◽  
Author(s):  
A. Høst ◽  
S. Halken ◽  
P. E. Andersen
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Prostaglandin E1 ◽  
Cortical Hyperostosis

scholarly journals Cortical Hyperostosis after Long-Lasting Prostaglandin E1 Treatment in a Newborn with Complex Congenital Heart Disease

2020 ◽  
Vol 226 ◽  
pp. 302-303 ◽  
Author(s):  
Antonio Celona ◽  
Claudio Giardina ◽  
Salvatore Pappalardo ◽  
Aurelio Secinaro ◽  
Lilia Oreto ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Prostaglandin E1 ◽  
Complex Congenital Heart Disease ◽  
Cortical Hyperostosis

Long-Term Prostaglandin E1 Infusion for Newborns with Critical Congenital Heart Disease

2015 ◽  
Vol 37 (1) ◽  
pp. 131-134 ◽  
Author(s):  
Alper Aykanat ◽  
Taner Yavuz ◽  
Elif Özalkaya ◽  
Sevilay Topçuoğlu ◽  
Fahri Ovalı ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Prostaglandin E1 ◽  
Critical Congenital Heart Disease

PROSTAGLANDIN E1 ADMINISTRATION TO PATIENTS WITH THE DUCTUS-DEPENDENT CONGENITAL HEART DISEASE

1990 ◽  
Vol 40 (6) ◽  
pp. 765-771
Author(s):  
KATSUHIKO SONE ◽  
TOSHIHIRO KOBAYASHI ◽  
TOMIO KOBAYASHI ◽  
TAKASHI KOSUDA ◽  
SANAYASU ONO ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Prostaglandin E1
Sign in / Sign up

Export Citation Format

Share Document